Sponsorship bias in clinical trials: growing menace or dawning realisation?
作者信息
Jefferson Tom
机构信息
Senior Associate Tutor, University of Oxford; Researcher, Nordic Cochrane Centre; Visiting Professor, Newcastle University, UK.
出版信息
J R Soc Med. 2020 Apr;113(4):148-157. doi: 10.1177/0141076820914242.
Abstract
摘要
相似文献
1
Sponsorship bias in clinical trials: growing menace or dawning realisation?临床试验中的赞助偏差：日益严重的威胁还是初现的认识？
J R Soc Med. 2020 Apr;113(4):148-157. doi: 10.1177/0141076820914242.
2
Small study on industry trial sponsorship leads to big questions about quality and bias.关于行业试验赞助的小型研究引发了有关质量和偏差的重大问题。
J Natl Cancer Inst. 2007 Jul 4;99(13):988-90. doi: 10.1093/jnci/djm057. Epub 2007 Jun 27.
3
Torcetrapib and atorvastatin--should marketing drive the research agenda?托彻普和阿托伐他汀——市场营销应推动研究议程吗？
N Engl J Med. 2005 Jun 23;352(25):2573-6. doi: 10.1056/NEJMp058075.
4
Search for evidence goes on.证据搜寻仍在继续。
BMJ. 2012 Jan 17;344:e458. doi: 10.1136/bmj.e458.
5
The Tamiflu trials.达菲试验。
BMJ. 2014 Apr 9;348:g2630. doi: 10.1136/bmj.g2630.
6
If the Facts Were Not Untruths, Their Implications Were: Sponsorship Bias and Misleading Communication.
Kennedy Inst Ethics J. 2018;28(2):119-144. doi: 10.1353/ken.2018.0011.
7
No evidence of industry sponsorship bias in statin trials.
BMJ. 2014 Nov 4;349:g6579. doi: 10.1136/bmj.g6579.
8
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports.行业资助的奥司他韦试验中的偏倚风险：核心报告与完整临床研究报告的比较
BMJ Open. 2014 Sep 30;4(9):e005253. doi: 10.1136/bmjopen-2014-005253.
9
Tug of war for antiviral drugs data.抗病毒药物数据的激烈争夺。
BMJ. 2014 Apr 9;348:g2227. doi: 10.1136/bmj.g2227.
10
The statin wars.他汀类药物之争
Lancet. 2003 Nov 1;362(9394):1498. doi: 10.1016/S0140-6736(03)14698-3.
引用本文的文献
1
Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials.精神分裂症阴性症状的药物干预：随机对照试验的系统评价
Biomedicines. 2025 Feb 21;13(3):540. doi: 10.3390/biomedicines13030540.
2
Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss.胰高血糖素样肽-1受体激动剂：减肥之外的令人兴奋的途径。
J Clin Med. 2025 Mar 14;14(6):1978. doi: 10.3390/jcm14061978.
3
Implementation of the EU's Health Technology Assessment regulation: where does existing methods guidance require concretization and what are the relevant methodological options?欧盟卫生技术评估法规的实施：现有方法指南在哪些方面需要具体化，相关的方法选项有哪些？
Int J Technol Assess Health Care. 2025 Feb 6;41(1):e9. doi: 10.1017/S0266462324004793.
4
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair.在择期初次髋关节或膝关节置换术或髋部骨折修复中，直接凝血因子Xa抑制剂与低分子量肝素或维生素K拮抗剂用于预防静脉血栓栓塞的比较
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD011762. doi: 10.1002/14651858.CD011762.pub2.
5
Conclusions of clinical trials assessing monoclonal antibodies and sponsored by pharmaceutical industry: a meta-research study.由制药行业赞助的评估单克隆抗体的临床试验结论：一项元研究。
Rev Assoc Med Bras (1992). 2024 Dec 2;70(11):e20241022. doi: 10.1590/1806-9282.20241022. eCollection 2024.
6
International Collaboration and Commercial Involvement in Randomized Controlled Trials From 10 Leading Countries, 1997 Through 2019.1997年至2019年10个主要国家随机对照试验中的国际合作与商业参与情况
Cureus. 2024 May 27;16(5):e61205. doi: 10.7759/cureus.61205. eCollection 2024 May.
7
Global Equity in Clinical Trials: An ASCO Policy Statement.全球临床试验中的公平性：美国临床肿瘤学会政策声明。
JCO Glob Oncol. 2024 Mar;10:e2400015. doi: 10.1200/GO.24.00015.
8
The quality of systematic reviews/meta-analyses assessing the effects of ankle-foot orthosis on clinical outcomes in stroke patients: A methodological systematic review.评估踝足矫形器对中风患者临床结局影响的系统评价/荟萃分析的质量：一项方法学系统评价。
Health Sci Rep. 2023 Mar 1;6(3):e1130. doi: 10.1002/hsr2.1130. eCollection 2023 Mar.
9
Industry influence in healthcare harms patients: myth or maxim?医疗保健行业的影响对患者有害：是谬论还是真理？
Breathe (Sheff). 2022 Jun;18(2):220010. doi: 10.1183/20734735.0010-2022. Epub 2022 Jul 12.
10
Moving towards less biased research.迈向偏差更小的研究。
BMJ Open Sci. 2021 Jan 17;5(1):e100116. doi: 10.1136/bmjos-2020-100116. eCollection 2021.
本文引用的文献
1
Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist.唐纳德·梅因兰：解剖学家、教育家、思想家、医学统计学家、试验专家、风湿病学家。
J R Soc Med. 2020 Jan;113(1):28-38. doi: 10.1177/0141076819896274.
2
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.他汀类药物治疗老年人的疗效和安全性：28 项随机对照试验个体参与者数据的荟萃分析。
Lancet. 2019 Feb 2;393(10170):407-415. doi: 10.1016/S0140-6736(18)31942-1.
3
When to include clinical study reports and regulatory documents in systematic reviews.何时将临床研究报告和监管文件纳入系统评价。
BMJ Evid Based Med. 2018 Dec;23(6):210-217. doi: 10.1136/bmjebm-2018-110963. Epub 2018 Oct 11.
4
Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.遵守在欧盟临床试验注册库中报告结果的要求：队列研究与网络资源
BMJ. 2018 Sep 12;362:k3218. doi: 10.1136/bmj.k3218.
5
Statin wars: have we been misled about the evidence? A narrative review.他汀类药物之争：我们是否被证据误导了？一篇叙述性综述。
Br J Sports Med. 2018 Jul;52(14):905-909. doi: 10.1136/bjsports-2017-098497. Epub 2018 Jan 21.
6
Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy.试验设计者和荟萃分析者的选择性偏倚可能会影响干预效果的结论。
J Clin Epidemiol. 2017 Nov;91:95-110. doi: 10.1016/j.jclinepi.2017.07.014. Epub 2017 Aug 24.
7
The Crucial Test of Therapeutic Evidence: Torald Sollmann, M.D., Cleveland.治疗证据的关键测试：医学博士托拉尔·索尔曼，克利夫兰
JAMA. 2017 Jul 18;318(3):304. doi: 10.1001/jama.2017.5060.
8
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review.已发表和未发表的医疗保健干预研究中不良事件的报告：一项系统评价。
PLoS Med. 2016 Sep 20;13(9):e1002127. doi: 10.1371/journal.pmed.1002127. eCollection 2016 Sep.
9
Interpretation of the evidence for the efficacy and safety of statin therapy.他汀类药物治疗疗效和安全性证据解读。
Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8.
10
Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.奥利司他试验的方案、临床研究报告和已发表论文中不良事件的评估：一项文献分析
PLoS Med. 2016 Aug 16;13(8):e1002101. doi: 10.1371/journal.pmed.1002101. eCollection 2016 Aug.
Zotero 插件